Alimera Sciences RSI
Was ist das RSI von Alimera Sciences?
RSI von Alimera Sciences Inc. ist 55.60
Was ist die Definition von RSI?
Der relative Stärke-Index (RSI 14) ist ein Momentumindikator, der die Größe von Gewinnen und Verlusten über einen bestimmten Zeitraum vergleicht, um die Geschwindigkeit und die Änderung von Preisbewegungen eines Wertpapiers zu messen.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Alimera Sciences
Was macht Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Unternehmen mit rsi ähnlich Alimera Sciences
- Maxcyte Inc Com Stk Usd0.01 (Di hat RSI von 55.58
- Maiden North America hat RSI von 55.58
- Deceuninck NV hat RSI von 55.58
- Keli Sensing Technology (Ningbo) Co hat RSI von 55.58
- General American Investors Co hat RSI von 55.59
- Ishares India U hat RSI von 55.59
- Alimera Sciences hat RSI von 55.60
- SS&C Technologies Inc hat RSI von 55.61
- Envision Solar International hat RSI von 55.61
- Cellectis hat RSI von 55.61
- Hecla Mining Co hat RSI von 55.61
- Goldsource Mines hat RSI von 55.61
- Metal Hawk hat RSI von 55.61